|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Nuvectis Pharma, Inc. (NVCT) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
12,720,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Nuvectis Pharma is a biopharmaceutical company focused on the development of medicines for the treatment of medical needs in oncology. Co. uses target selection, drug profiling, and clinical and regulatory execution to build a pipeline of anticancer targeted-therapy drugs. Co. is developing two preclinical drug candidates, NXP800 and NXP900. NXP800 is an oral small molecule inhibitor of the Heat Shock Factor 1 pathway. NXP800 targets ovarian clear cell carcinoma and endometrioid ovarian cancer. NXP900 is an oral small molecule designed to inhibit the SRC and YES1 kinases. NXP900 is in preclinical development with IND-enabling studies.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
5,553 |
15,493 |
230,942 |
Total Buy Value |
$0 |
$36,055 |
$142,157 |
$3,634,800 |
Total People Bought |
0 |
3 |
3 |
4 |
Total Buy Transactions |
0 |
4 |
10 |
65 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Poradosu Enrique |
Chief Science & Business Off |
|
2022-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
1,257,649 |
|
- |
|
Bentsur Ron |
Chairman & CEO |
|
2022-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
120,000 |
2,945,459 |
|
- |
|
Bentsur Ron |
Chairman & CEO |
|
2022-03-28 |
4 |
B |
$7.05 |
$28,200 |
D/D |
4,000 |
2,825,459 |
3.23 |
- |
|
Carson Michael J. |
Vice President, FinanceOfficer |
|
2022-03-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
27,300 |
|
- |
|
Bentsur Ron |
Chairman & CEO |
|
2022-03-17 |
4 |
B |
$7.63 |
$53,410 |
D/D |
7,000 |
2,821,459 |
3.23 |
- |
|
Bentsur Ron |
Chairman & CEO |
|
2022-02-14 |
4 |
B |
$5.88 |
$47,040 |
D/D |
8,000 |
2,814,459 |
2.81 |
- |
|
Bentsur Ron |
Chairman & CEO |
|
2022-02-10 |
4 |
B |
$6.34 |
$53,890 |
D/D |
8,500 |
2,806,459 |
2.81 |
- |
|
Ben-Or Uri |
Int. Principal Financial Off.O |
|
2022-02-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,584 |
|
- |
|
Bentsur Ron |
Chairman & CEOOfficer |
|
2022-02-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,565,459 |
|
- |
|
Shemesh Shay |
Chief Development OfficerOffic |
|
2022-02-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,176,669 |
|
- |
|
Kaplan Matthew L. |
Director |
|
2022-02-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
32,760 |
|
- |
|
Oliviero James F Iii |
Director |
|
2022-02-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,828 |
|
- |
|
Hoberman Kenneth |
Director |
|
2022-02-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
49,140 |
|
- |
|
Shemesh Shay |
Chief Development Officer |
|
2022-02-07 |
4 |
B |
$3.47 |
$2,936 |
D/D |
846 |
1,179,615 |
2.66 |
- |
|
Poradosu Enrique |
Chief Science & Business Off |
|
2022-02-07 |
4 |
B |
$3.88 |
$3,104 |
D/D |
800 |
1,197,649 |
2.66 |
- |
|
Bentsur Ron |
Chairman & CEO |
|
2022-02-07 |
4 |
B |
$3.93 |
$104,520 |
D/D |
20,000 |
2,797,959 |
2.81 |
- |
|
Shemesh Shay |
Chief Development Officer |
|
2022-02-04 |
4 |
B |
$3.38 |
$7,098 |
D/D |
2,100 |
1,178,769 |
2.74 |
- |
|
Poradosu Enrique |
Chief Science & Business Off |
|
2022-02-04 |
4 |
B |
$3.35 |
$12,730 |
D/D |
3,800 |
1,196,849 |
2.74 |
- |
|
Bentsur Ron |
Chairman & CEO |
|
2022-02-04 |
4 |
B |
$3.89 |
$1,048,625 |
D/D |
212,500 |
2,777,959 |
2.81 |
- |
|
119 Records found
|
|
Page 5 of 5 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|